This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
EMD Millipore
other brands :
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type :
antibody
product name :
Zinc Finger Protein 217 Antibody, clone 8C11
catalog :
MABE434
quantity :
100 μg
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
8C11
reactivity :
human
application :
western blot
citations: 3
Published Application/Species/Sample/Dilution | Reference |
---|---|
| |
product information
Catalog Number :
MABE434
Subcategory :
Epigenetics & Nuclear Function
Product Name :
Anti-Zinc Finger Protein 217 Antibody, clone 8C11
Product Type :
Antibodies
Clonality :
Monoclonal Antibody
Gene ID :
O75362
Host Name :
Mouse
Antigen :
Zinc Finger Protein 217
Clone :
8C11
Conjugate :
Purified
Isotype :
IgG2bκ
Product Description :
Anti-Zinc Finger Protein 217 Antibody, clone 8C11
Cross Reactivity :
Human
Background :
Zinc finger protein 217 (ZNF217) is a member of the krueppel C2H2-type zinc-finger protein family, and functions as a transcriptional repressor by binding to the promoter regions of target genes. Zinc finger protein 217 is involved in phosphorylation of AKT1 at 'Ser-473', promotes cell proliferation and antagonizes cell death.
ALT Names :
Zinc finger protein 217
Immunogen :
Recombinant protein corresponding to a truncated form of human Zinc Finger Protein 217.
Package Size :
100 μg
Uses :
Western Blotting
Storage :
Stable for 1 year at 2-8°C from date of receipt
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany
Hundreds of New Antibodies in the areas of:
View all the new antibodies at www.emdmillipore.com.
Hundreds of New Antibodies in the areas of:
|
|
questions and comments